insights_auto
Why is MESO down ၂.၈၇%?
Dive Deeperchevron_right
MESO:NASDAQ
Mesoblast Ltd
၁၄.၂၃ US$
arrow_downward
-၂.၈၇%(-၀.၄၂) 1D
အောက် ၁, GMT-၄ ၁၁:၅၅:၄၂ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MESO...
Open
၁၄.၄၄ US$
High
၁၄.၄၉ US$
Low
၁၄.၁၉ US$
Mkt. cap
၁၈၄.၈၁ ဋေ
Avg. vol.
၂.၀၂ သိန်း
Volume
၁.၀၆ သိန်း
52-wk high
၂၁.၄၉ US$
52-wk low
၁၃.၀၅ US$
EPS
-၀.၄၄ US$
Beta
၂.၁၂
Shares outstanding
၁၂.၉၉ ကုဋေ
No. of employees
၁၀၈
Open
၁၄.၄၄ US$
High
၁၄.၄၉ US$
Low
၁၄.၁၉ US$
Mkt. cap
၁၈၄.၈၁ ဋေ
Avg. vol.
၂.၀၂ သိန်း
Volume
၁.၀၆ သိန်း
52-wk high
၂၁.၄၉ US$
52-wk low
၁၃.၀၅ US$
EPS
-၀.၄၄ US$
Beta
၂.၁၂
Shares outstanding
၁၂.၉၉ ကုဋေ
No. of employees
၁၀၈
News stories
From web sources and news partners
Kalkine
·
ပြီးခဲ့သည့် ၂ နာရီ
Mesoblast Limited (ASX:MSB) Builds Ryoncil Revenue Base as FY26 Loss Narrows
TipRanks
·
ပြီးခဲ့သည့် ၆ နာရီ
State Street Group Cuts Mesoblast Stake Below Substantial Holder Threshold
Kalkine Media
·
ပြီးခဲ့သည့် ၁၄ နာရီ
Why Are Mesoblast (ASX:MSB) Shares Slipping Despite FDA Approval?
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
About Mesoblast Ltd